🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Denmark / NCT05010356
Recruiting Not applicable

Insulin Sensitivity After Breast Cancer

NCT05010356 · tracked via the Priya Life Science Denmark tracker
Phase
Not applicable
Started
2021-08
Last updated
2021-08-18

Condition(s) studied

Insulin Sensitivity/ResistanceBreast CancerSurvivorshipMetabolic Disturbance

Investigational drug(s) / intervention(s)

Insulin

Insulin: Hyperinsulinemic euglycemic clamp

Study summary

Epidemiological studies have revealed that 60-80% of women with breast cancer (BC) develop metabolic disorders that are similar to those observed in conditions like type 2 diabetes. These metabolic disorders, including insulin resistance, obesity, hyperinsulinemia, and glucose intolerance, are associated with increased BC recurrence and mortality. Skeletal muscle is the major site of glucose uptake in humans. The aims of the present project are to 1) determine the involvement of insulin resistance in skeletal muscle in the metabolic disorders prevalent in BC survivors, 2) identify BC-and/or treatment-induced molecular changes in skeletal muscle from BC survivors .

Eligibility

Sex
FEMALE
Min age
20 Years
Max age
45 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Premenopausal women operated for breast cancer and after completing adjuvant chemotherapy and no earlier than 3 weeks after its termination * BMI: 25-30 * Healthy controls will be included matched by gender, weight, age, and level of physical activity to the patient group included as subjects Exclusion Criteria: * Known postmenopause occurred at the time of diagnosis of breast cancer * Alcohol intake of\> 7 items / week * Smoker * Already known Type 2 diabetes mellitus or metabolic syndrome and medical treatment thereof. * Cardiovascular disease and its medical treatment * Impaired mobility

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University of Copenhagen Copenhagen DK Recruiting

More University of Copenhagen trials in Denmark

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05010356 on ClinicalTrials.gov ↗ ← All trials in Denmark